Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 54Stomach Neoplasms 42Carcinoma, Non-Small-Cell Lung 31Colorectal Neoplasms 21Esophageal Squamous Cell Carcinoma 15Nasopharyngeal Carcinoma 11Lung Neoplasms 11Rectal Neoplasms 10Esophageal Neoplasms 9Pancreatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 5Neoplasms 5Liver Neoplasms 5Cholangiocarcinoma 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Recurrence 4Neoplasm Metastasis 4Carcinoma, Renal Cell 4Lymphoma, Extranodal NK-T-Cell 3Colorectal Cancer Metastatic 3Colonic Neoplasms 3Carcinoma 3Breast Neoplasms 3Turcot syndrome 2Thyroid Neoplasms 2Spinocerebellar Degenerations 2Sarcoma 2Nonsquamous Non-Small Cell Lung Cancer 2

Interventions

nintedanib 2durvalumab 2Radiotherapy 2Immunotherapy 2tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1camrelizumab 1beclomethasone 17-monopropionate 1aumolertinib 1atezolizumab 1apatinib 1Tomography, Emission-Computed, Single-Photon 1Surveys and Questionnaires 1Respiratory Function Tests 1Prednisone 1Nivolumab 1Nicorandil 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Hyperbaric Oxygenation 1Esophagectomy 1Disulfides 1Dexamethasone 1Cisplatin 1Breath Holding 1Angiogenesis Inhibitors 1Adrenal Cortex Hormones 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiation Pneumonitis × sintilimab × Clear all
NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Zhejiang Cancer Hospital

Phase 3 Unknown
105 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡